A detailed history of Oppenheimer Asset Management Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 79,915 shares of DXCM stock, worth $6.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
79,915
Previous 133,908 40.32%
Holding current value
$6.1 Million
Previous $15.2 Million 64.73%
% of portfolio
0.07%
Previous 0.2%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$64.0 - $116.06 $3.46 Million - $6.27 Million
-53,993 Reduced 40.32%
79,915 $5.36 Million
Q2 2024

Aug 08, 2024

BUY
$110.31 - $140.45 $1.92 Million - $2.45 Million
17,443 Added 14.98%
133,908 $15.2 Million
Q1 2024

May 06, 2024

SELL
$114.22 - $140.1 $663,732 - $814,121
-5,811 Reduced 4.75%
116,465 $16.2 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $2.53 Million - $4.17 Million
33,580 Added 37.86%
122,276 $15.2 Million
Q3 2023

Nov 07, 2023

SELL
$86.06 - $137.93 $164,116 - $263,032
-1,907 Reduced 2.1%
88,696 $8.28 Million
Q2 2023

Aug 02, 2023

SELL
$112.47 - $130.98 $94,362 - $109,892
-839 Reduced 0.92%
90,603 $11.6 Million
Q1 2023

May 10, 2023

SELL
$104.0 - $122.92 $356,720 - $421,615
-3,430 Reduced 3.62%
91,442 $10.6 Million
Q4 2022

Feb 06, 2023

SELL
$84.98 - $122.67 $181,772 - $262,391
-2,139 Reduced 2.2%
94,872 $10.7 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $131,703 - $162,460
-1,725 Reduced 1.75%
97,011 $7.81 Million
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $5.05 Million - $9.87 Million
74,253 Added 303.28%
98,736 $7.36 Million
Q1 2022

May 12, 2022

BUY
$94.08 - $130.2 $23,802 - $32,940
253 Added 1.04%
24,483 $12.5 Million
Q4 2021

Feb 02, 2022

BUY
$129.87 - $162.82 $72,337 - $90,690
557 Added 2.35%
24,230 $13 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $55,382 - $74,310
519 Added 2.24%
23,673 $12.9 Million
Q2 2021

Aug 03, 2021

BUY
$80.99 - $107.93 $305,008 - $406,464
3,766 Added 19.42%
23,154 $9.89 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $51,043 - $63,053
602 Added 3.2%
19,388 $6.97 Million
Q4 2020

Feb 11, 2021

BUY
$78.0 - $104.5 $16,458 - $22,049
211 Added 1.14%
18,786 $6.95 Million
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $58,738 - $69,464
615 Added 3.42%
18,575 $7.66 Million
Q2 2020

Aug 11, 2020

BUY
$62.68 - $105.34 $9,402 - $15,801
150 Added 0.84%
17,960 $7.28 Million
Q1 2020

May 08, 2020

BUY
$47.79 - $75.63 $6,308 - $9,983
132 Added 0.75%
17,810 $4.8 Million
Q4 2019

Feb 07, 2020

BUY
$36.62 - $57.29 $12,853 - $20,108
351 Added 2.03%
17,678 $3.87 Million
Q3 2019

Oct 31, 2019

BUY
$35.53 - $43.8 $15,775 - $19,447
444 Added 2.63%
17,327 $2.59 Million
Q2 2019

Aug 09, 2019

SELL
$27.84 - $38.92 $6,486 - $9,068
-233 Reduced 1.36%
16,883 $2.53 Million
Q1 2019

Apr 24, 2019

BUY
$28.07 - $38.18 $477,639 - $649,670
17,016 Added 17016.0%
17,116 $2.04 Million
Q4 2018

Jan 30, 2019

BUY
$26.99 - $37.37 $2,699 - $3,736
100 New
100 $12,000
Q1 2018

May 09, 2018

SELL
$13.06 - $18.54 $70,641 - $100,282
-5,409 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $61,446 - $102,662
5,409
5,409 $265,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.